Patient Guide: A Study to Evaluate the Efficacy and Safety of HLX11 vs. EU-Perjeta® in the Neoadjuvant Therapy of HER2-Positive and HR-Negative Early-stage or Locally Advanced Breast Cancer

We'll Help You Connect with This Trial

Quri.ai is a free clinical trial matching service. We help patients like you connect directly with research sites conducting this study.

  • Get matched to the right study location for you
  • Connect directly with study coordinators at 79 participating sites
  • Understand eligibility with our simplified screening tool
  • Free service - we're here to help you access clinical research
Trial ID: NCTNCT05346224
Status: ACTIVE_NOT_RECRUITING
Condition: Breast Cancer, Breast Neoplasms, HER2-positive Breast Cancer
Phase: PHASE3

Find a Study Location Near You

This study is available at 79 research sites. We'll help you connect with the location that's right for you.

Participating sites include:
  • Bengbu, Anhui
  • Hefei, Anhui
  • Hefei, Anhui
  • • And 76 more locations - let us help you find the closest one

Loading interactive enrollment tools...

The full interactive experience will load momentarily